Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version

Profile of registrant

Grünenthal GmbH

Identification number in the register: 67826544528-01
Registration date: 14/11/10 18:46:49

The information on this organisation was last modified on 20/10/14 09:16:41
The date of the last annual update was 20/10/14 09:16:41

Registrant : Organisation or self-employed individual

Name/company name: Grünenthal GmbH
Acronym: Grünenthal
Legal status: Gesellschaft mit beschränkter Haftung
Website address:


Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  Eric-Paul Pâques
Position: Chairman of the Corporate Executive Board

Permanent person in charge of EU relations

Surname, Name: Mr  Konrad Labuschagne
Position: Governmental Affairs and Health Policy

Contact details:

Contact details of organisation's head office: 6 Zieglerstraße 
Aachen D-52099
Telephone number: (+49) 241 569 0
Fax number: (+49) 241 569 3474
Other contact information:

Goals / remit

Goals / remit of the organisation: The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation.

Grünenthal is one of the last five remaining research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. Research and development costs amounted to about 27 percent of revenues in 2013. Grünenthal's research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. We are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies.

Altogether, the Grünenthal Group has affiliates in 25 countries worldwide. Grünenthal products are sold in more than 155 countries and approx. 5,500 employees are working for the Grünenthal Group worldwide. In 2013, Grünenthal achieved revenues of €901 mn.

More information:
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 1
Complementary information:

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Konrad Labuschagne 21/05/14 19/05/15


Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:

Grünenthal supports the multistakeholder platform "Sociatal Impact of Pain" (SIP, Furthermore Grünenthal activities in Brussels deal with issues related to healthcare, pain care, pharmaceuticals, innovation and research and intellectual property.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Competition
  • Customs
  • Economic and Financial Affairs
  • Employment and Social Affairs
  • Enlargement
  • Enterprise
  • General and Institutional Affairs
  • Humanitarian Aid
  • Internal Market
  • Public Health
  • Regional Policy
  • Research and Technology
  • Taxation
  • Trans-European Networks


Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.

Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA)

Financial data

Financial year: 01/2013 - 01/2014
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: < 50000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.